EMEA-002059-PIP02-19-M01

Table of contents

Key facts

Active substance
Fasinumab
Therapeutic area
Pain
Decision number
P/0287/2021
PIP number
EMEA-002059-PIP02-19-M01
Pharmaceutical form(s)
Solution for injection
Condition(s) / indication(s)
  • Treatment of chronic musculoskeletal pain
  • Treatment of chronic non-musculoskeletal pain
Route(s) of administration
Subcutaneous use
Contact for public enquiries
Regeneron Ireland DAC

Tel. +1 9148 475385
E-mail: clinicaltrials@regeneron.com
Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating